FEB 18, 2016 10:11 AM PST

Dramatic Remissions Seen in Immunotherapy Trial

WRITTEN BY: Julianne Chiaet

 
Dr. Stanley RiddellDramatic remissions have been seen in a cancer immunotherapy trial for patients with blood cancers. Specifically, 27 out of 29 patients with advanced blood cancer sustained remissions with this treatment. The results are preliminary as the study is ongoing at the Fred Hutchinson Cancer Research Center in Seattle.

Immunotherapy is a revolutionary approach to fighting cancer. The treatment is still experimental, so it is generally reserved for those whose cancer was resistant to other cancer-fighting treatments. The trial began in 2013, and many of the recruited patients were not expected to survive for more than a few months.

The team at Fred Hutchinson uses an immunotherapy technique called adoptive T-cell therapy. The treatment works by first taking a patient’s T-cells, a type of white blood cell. T cells have the ability to detect and attack foreign or abnormal cells. Unfortunately, cancer can exhaust and overpower T cells. In addition, tumors use an array of techniques to evade them.

After taking the T cells, the researchers then genetically engineer them with synthetic molecules called chimeric antigen receptors (CAR). The CARs enable the T cells to attack the body’s cancer cells. The army of cancer-fighting cells is grown in a lab and then given back to the patient. The therapy does not need to be repeatedly administered because T cells can continue to multiply once delivered back into the patient.

The researchers noticed dramatic remissions in the treatment of patients with two types of cancers: lymphomas and some types of leukemias. However, while the treatment shows promising results, “much like chemotherapy and radiotherapy, it’s not going to be a save-all,” said Immunotherapy researcher and oncologist Stanley Riddell. Some patients may require alternative treatments.

Ridell and his colleagues are continuously revising the T-cell therapy protocols in hopes to make the therapy more effective and reduce the harmful side effects. The side effects, sometimes serious, have included fevers, drops in blood pressure, neurological symptoms, and cytokine release syndrome. Seven patients in the study ended up in intensive care due to the side effects. Two of the study participants died. The team found that administering the lowest dose of T cells to those with the highest tumor burdens lowered the risk of serious side effects.

The researchers are now working on developing safer and easier to design T cells. It is important to note that the research has not yet been published, and has thus not been evaluated by scientists independent of the study.

Riddell shared the trial results on Sunday at the American Association for the Advancement of Science in Washington D.C.

Sources: Fred Hutchinson Cancer Research Center: Hutch News, RT America video
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
OCT 08, 2020
Immunology
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
OCT 08, 2020
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
Tiny, black particles much like those found in polluted air have been found in the placentas of pregnant women, as repor ...
OCT 09, 2020
Microbiology
Two Early Relatives of Rubella Are Discovered
OCT 09, 2020
Two Early Relatives of Rubella Are Discovered
Rubella is a contagious, airborne viral infection that can lead to rash, fever, and sore throat. It's especially dangero ...
OCT 19, 2020
Genetics & Genomics
Early Childhood Trauma Affects Metabolism in the Next Generation
OCT 19, 2020
Early Childhood Trauma Affects Metabolism in the Next Generation
Traumatic experiences can have a lasting impact, and kids that suffer through them can feel the effects for a lifetime. ...
OCT 29, 2020
Cardiology
Treating Cardiovascular Calcification at the Source
OCT 29, 2020
Treating Cardiovascular Calcification at the Source
The term cardiovascular disease covers a broad array of health problems. Everyone tends to think of heart attacks or hyp ...
OCT 24, 2020
Genetics & Genomics
Cord Blood Samples Reveal More About the Genetics of Autism
OCT 24, 2020
Cord Blood Samples Reveal More About the Genetics of Autism
The activity of genes in our genome is controlled by many factors, one of which are chemical tags or structural changes ...
OCT 26, 2020
Genetics & Genomics
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
OCT 26, 2020
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
People that eat a 'paleo' diet operate under the idea that we should be eating more like our ancestors, and that metabol ...
Loading Comments...